Skip to main content
Clinical Trials/NCT05992870
NCT05992870
Recruiting
Not Applicable

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

Hubei Cancer Hospital1 site in 1 country40 target enrollmentJuly 8, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Hubei Cancer Hospital
Enrollment
40
Locations
1
Primary Endpoint
Postoperative complications at 3 months following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Neoadjuvant radiotherapy(NART) followed by mastectomy and immediate DIEP flap reconstruction is feasible and technically safe. However, reports of NACT followed immediate implant-based breast reconstruction are rare. Some studies have shown that NART followed immediate implant-based breast reconstruction seems feasible and can be safely attempted. It's well known that radiotherapy after implant-based breast reconstruction have negative effects on implant and cosmetic results. So, investigators conducted a polit study to learn about acute post-surgical complications following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART.

Detailed Description

Radiotherapy after implant-based breast reconstruction have negative effects on implant and cosmetic results, including severe capsular contracture, mastectomy flap necrosis ,reoperation and so on. Postmastectomy radiotherapy( PMRT )is associated with implant reconstruction failure. PRADA study has shown neoadjuvant radiotherapy followed by skin-sparing mastectomy and immediate DIEP flap reconstruction is feasible and technically safe. The investigators assume that neoadjuvant radiotherapy can avoid the negative effects of PMRT on an implant and the capsule of an implant and would lead to better cosmetic results and less complications compared to PMRT. Furthermore, some studies have shown that NART could potentially result in shorter time between diagnosis and treatment completion. So, investigators conducted a polit study to learn about acute post-surgical complications following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART.

Registry
clinicaltrials.gov
Start Date
July 8, 2023
End Date
October 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Hubei Cancer Hospital
Responsible Party
Principal Investigator
Principal Investigator

Xinhong Wu, PhD

vice-president

Hubei Cancer Hospital

Eligibility Criteria

Inclusion Criteria

  • Women \>18 years with histopathologically-confirmed breast cancer, who:
  • require mastectomy for any reason
  • a known indication for (adjuvant) radiotherapy
  • require implant-based breast reconstruction

Exclusion Criteria

  • Inability to give informed consent
  • MDT unable to make recommendation for radiotherapy based on pre-operative histopathological and imaging findings
  • Previous history of breast cancer or another malignancy for which radiotherapy of the breast or axilla
  • Pregnant or lactating
  • inflammatory breast cancer

Outcomes

Primary Outcomes

Postoperative complications at 3 months following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART

Time Frame: 3 months following skin-sparing mastectomy and immediate breast reconstruction

Surgical complications are defined as any complication requiring surgical intervention necessary within a period up to three months after the final reconstruction. Including Infection, hematoma , loss of implant or flap, fat necrosis, wound breakdown,defined and scored using the C-DC37.

Secondary Outcomes

  • Patient satisfaction.(3 months and 12 months after surgery)
  • Number of participants with removal of implant.(6 months after surgery)
  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 .(Within 3 months after both breast reconstruction and radiotherapy)
  • Pathological complete response (pCR) assessed in skin-sparing mastectomy specimen(Within 2 weeks after skin-sparing mastectomy)

Study Sites (1)

Loading locations...

Similar Trials